All In Biotech

Drug Trial Radar · NCT07222137

A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults

A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of Baricitinib to Delay Stage 3 Type 1 Diabetes in At-risk Participants Aged ≥1 to <36 Years

Last checked: Nov 20, 2026Latest source record: Nov 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 150 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

150

Planned (sponsor's estimate)

Start

Jan 12, 2026

Primary completion

Jul 2031

Study completion Jul 2031

Sponsor

Lead sponsor
Eli Lilly and CompanyEli Lilly (LLY)
Sponsor type
Industry
First posted
Oct 29, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 1 year, up to 35 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to find out if baricitinib can delay the onset of clinical type 1 diabetes (T1D) in people who are at high risk to develop T1D. Participation in the study will last up to approximately 5 years.

Conditions

  • Diabetes Mellitus, Type 1

Interventions

  • BaricitinibDrug

    Administered orally

  • PlaceboDrug

    Administered orally

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Time from Baseline to Diagnosis of Stage 3 Type 1 DiabetesTime frame: Baseline up to approximately 5 years

Locations

112 sites in 19 countries. Site status is shown where the registry gives one.

  • Sansum Diabetes Research Institute

    Santa Barbara, California · Not yet recruiting

  • Tallahassee Memorial HealthCare

    Tallahassee, Florida · Recruiting

  • University of Iowa

    Iowa City, Iowa · Recruiting

  • Iowa Diabetes and Endocrinology Research Center

    West Des Moines, Iowa · Recruiting

  • Novak Center for Children's Health

    Louisville, Kentucky · Recruiting

  • Children's Hospital of Philadelphia (CHOP)

    Philadelphia, Pennsylvania · Not yet recruiting

  • University of Virginia

    Charlottesville, Virginia · Recruiting

  • Women's and Children's Hospital

    Adelaide, Australia · Recruiting

  • Box Hill Hospital

    Box Hill, Australia · Recruiting

  • Royal Brisbane and Women's Hospital

    Brisbane, Australia · Recruiting

  • Centre for Children's Health Research

    Brisbane, Australia · Recruiting

  • Royal Children's Hospital

    Melbourne, Australia · Recruiting

  • The Royal Melbourne Hospital

    Parkville, Australia · Recruiting

  • Perth Children's Hospital

    Perth, Australia · Recruiting

  • Sydney Children's Hospital

    Randwick, Australia · Recruiting

  • The Children's Hospital at Westmead

    Westmead, Australia · Recruiting

  • UZ Brussel

    Brussels, Belgium · Recruiting

  • Cliniques universitaires Saint-Luc

    Brussels, Belgium · Recruiting

  • Antwerp University Hospital

    Edegem, Belgium · Recruiting

  • UZ Leuven

    Leuven, Belgium · Recruiting

  • CHU UCL Namur/Site Sainte Elisabeth

    Namur, Belgium · Recruiting

  • Freire Pesquisa Clínica

    Belo Horizonte, Brazil · Recruiting

  • Centro de Diabetes Curitiba

    Curitiba, Brazil · Recruiting

  • Hospital Universitario Walter Cantidio

    Fortaleza, Brazil · Recruiting

  • Cendi - Endocrinologia e Diabetes

    Goiânia, Brazil · Recruiting

  • Centro de Pesquisa Clínica de Marília - CPCLIM

    Marília, Brazil · Recruiting

  • Universidade Federal do Rio de Janeiro

    Rio de Janeiro, Brazil · Recruiting

  • Instituto de Pesquisa Clinica

    São Paulo, Brazil · Recruiting

  • CPCLIN

    São Paulo, Brazil · Recruiting

  • IBTED - Tecnologia e Educação em Diabetes

    São Paulo, Brazil · Recruiting

  • Hospital das Clinicas FMUSP

    São Paulo, Brazil · Recruiting

  • Alberta Children's Hospital

    Calgary, Canada · Not yet recruiting

  • Alberta Diabetes Institute

    Edmonton, Canada · Recruiting

  • BC Diabetes Office

    Vancouver, Canada · Recruiting

  • Oulun yliopistollinen sairaala

    Oulu, Finland · Recruiting

  • Tampereen yliopistollinen sairaala

    Tampere, Finland · Recruiting

  • Turku University Hospital

    Turku, Finland · Recruiting

  • Hospices Civils de Lyon - Hopital Louis Pradel

    Bron, France · Not yet recruiting

  • Centre Hospitalier Sud Francilien

    Corbeil-Essonnes, France · Not yet recruiting

  • Hopital Claude Huriez - CHU de Lille

    Lille, France · Not yet recruiting

Showing 40 of 112 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.